736 results on '"Dangas G"'
Search Results
2. New criteria to identify patients at higher risk for cardiovascular complications after percutaneous coronary intervention
3. Mortality after periprocedural myocardial injury and spontaneous myocardial infarction according to the levels of troponin increase: insights from a large PCI registry
4. Repeat coronary revascularization in high-risk patients treated with ticagrelor monotherapy after PCI: Insights from the randomized TWILIGHT trial
5. Predictors of Major Adverse Cardiovascular Events in Young Patients Undergoing Percutaneous Coronary Intervention
6. A mobile application for STEMI care optimization: pilot implementation project report
7. Prevalence and impact of TWILIGHT criteria in all-comer patients undergoing percutaneous coronary intervention
8. Impact of body mass index on outcomes in patients undergoing percutaneous coronary intervention for in-stent restenosis
9. Impact of different antiplatelet therapy cessation modes on outcomes in patients treated with ticagrelor with or without aspirin after PCI: the twilight-antiplatelet cessation study
10. Effect of aspirin discontinuation according to individualised patient bleeding and ischemic risks after PCI: a TWILIGHT trial sub-analysis
11. Safety and efficacy of biodegradable polymer biolimus-eluting stents in patients with non-ST-elevation acute coronary syndrome: a pooled analysis of GLASSY and TWILIGHT
12. Sex‐based differences in outcomes with bivalirudin or unfractionated heparin for transcatheter aortic valve replacement: Results from the BRAVO‐3 randomized trial
13. SGLT-2 inhibitors in patients with and without a history of heart failure: a meta-analysis
14. Guided and unguided de-escalation from potent P2Y12 inhibitors among patients with ACS: a meta-analysis
15. Impact of dual antiplatelet non-adherence after percutaneous coronary intervention in patients with or without history of myocardial infarction
16. Prognostic significance of cardiac amyloidosis in patients with aortic stenosis: a systematic review and meta-analysis
17. A Controlled Trial of Rivaroxaban after Transcatheter Aortic-Valve Replacement
18. Colchicine as a potent anti-inflammatory treatment in COVID-19: Can we teach an old dog new tricks?
19. Effect of Colchicine vs Standard Care on Cardiac and Inflammatory Biomarkers and Clinical Outcomes in Patients Hospitalized with Coronavirus Disease 2019: The GRECCO-19 Randomized Clinical Trial
20. Bleeding Risk, Dual Antiplatelet Therapy Cessation, and Adverse Events after Percutaneous Coronary Intervention: The PARIS Registry
21. Impact of high-density lipoprotein levels in males and females undergoing percutaneous coronary intervention with drug eluting stents
22. Randomized clinical trial comparing a rivaroxaban-based with an antiplatelet-based strategy for cerebral embolization after TAVR (EARTH TAVR)-a magnetic resonance imaging substudy of the GALILEO trial
23. Are the minor high bleeding risk criteria of the academic research consortium truly minor? Insights from a high-volume tertiary care pci centre
24. Intersection of the Academic Research Consortium – high bleeding risk criteria in patients undergoing PCI for acute coronary syndromes: insights from a high-volume single centre registry
25. Diabetes mellitus in transfemoral transcatheter aortic valve implantation in 11,440 patients from the CENTER collaboration
26. Radial versus femoral access for coronary angiography and interventions: a systematic review and meta-analysis of randomized trials
27. Long-term outcomes in high-bleeding risk patients undergoing PCI for acute coronary syndromes: results from a large single-center pci registry
28. 2349Selatogrel, a novel P2Y12 inhibitor for emergency use, achieves rapid, consistent and sustained platelet inhibition following single-dose subcutaneous administration in stable CAD patients
29. Transfemoral TAVR in Nonagenarians: From the CENTER Collaboration
30. Effect of renal denervation on blood pressure in the presence of antihypertensive drugs: 6-month efficacy and safety results from the SPYRAL HTN-ON MED proof-of-concept randomised trial
31. Effect of renal denervation on blood pressure in the presence of antihypertensive drugs: 6-month efficacy and safety results from the SPYRAL HTN-ON MED proof-of-concept randomised trial
32. Catheter-based renal denervation in patients with uncontrolled hypertension in the absence of antihypertensive medications (SPYRAL HTN-OFF MED): a randomised, sham-controlled, proof-of-concept trial
33. Catheter-based renal denervation in patients with uncontrolled hypertension in the absence of antihypertensive medications (SPYRAL HTN-OFF MED): a randomised, sham-controlled, proof-of-concept trial
34. Pharmacology in Structural Intervention for Valvular Heart Disease: Current Practice and Future Perspectives
35. A Controlled Trial of Rivaroxaban after Trans catheter Aortic-Valve Replacement.
36. P1652Effect of systemic inflammation and coronary artery disease complexity on outcomes after percutaneous coronary intervention
37. P6435Impact of persistent high C-reactive protein levels on all-cause mortality in patients after percutaneous coronary interventions
38. Prediction, staging, and outcomes of ischaemic cardiogenic shock after STEMI: a complex clinical interplay
39. 2927Sex-related differences in patients undergoing complex coronary interventions in the era of 2nd generation DES
40. P6114Characteristics and clinical outcomes in patients undergoing PCI by levels of high-density lipoproteins
41. P1389Impact of peripheral arterial disease on provision of discharge pharmacotherapy and longitudinal outcomes in patients with stable angina undergoing percutaneous coronary interventions
42. P2069Multivessel PCI versus culprit-vessel only PCI in patients with acute myocardial infarction and multivessel disease
43. Chapter 20 - Management of Patients after Acute Coronary Syndrome
44. OC10_02 Impact of Diabetes Mellitus on Patients With Human Immunodeficiency Virus Undergoing Percutaneous Coronary Intervention: Results From a Large, Single Center Registry
45. The Future for Transcatheter Aortic Valve Implantation
46. Facilitated/Pharmaco-invasive Approaches in STEMI
47. Erratum: Impact of intravascular ultrasound imaging on early and late clinical outcomes following percutaneous coronary intervention with drug-eluting stents. J Am Coll Cardiol Intv 2011;4:97481
48. Percutaneous treatment of left side cardiac valves: A practical guide for the interventional Cardiologist
49. Lower 30-Day Mortality after Early Stent Thrombosis with Bivalirudin vs Heparin
50. First in man clinical outcome of the CATANIA coronary stent system with nanothin Polyzene-F in de novo native coronary artery lesions: Assessment of the latest non thrombogenic angioplasty stent (ATLANTA) trial
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.